✦ LIBER ✦

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review

✍ Scribed by Fritz Schröder; Michael W. Kattan

Book ID: 113610853
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 326 KB
Volume: 54
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2008.05.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does the Extent of Carcinoma in Prostati

Does the Extent of Carcinoma in Prostatic Biopsies Predict Prostate-Specific Antigen Recurrence? A Systematic Review

✍ Patricia Harnden; Michael D. Shelley; Brian Naylor; Bernadette Coles; Malcolm D. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Predicting the outcome of prostate biops

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone

✍ David J. Hernandez; Misop Han; Elizabeth B. Humphreys; Leslie A. Mangold; Samir 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru

Percentage of core lengths involved with

Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

✍ Patrick W Linson; Andrew K Lee; Tatiana Doytchinova; Ming-Hui Chen; Michael H We 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A comparative performance analysis of to

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy

✍ Marco Auprich; Herbert Augustin; Lars Budäus; Luis Kluth; Sebastian Mannweiler; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

A Thematic Review of Men's Experiences D

A Thematic Review of Men's Experiences During the Waiting Period Between Prostate-Specific Antigen and Prostate Biopsy Results

✍ Susan Heyes; Ann Harrington; Jan Paterson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB